e-learning
resources
Vienna 2009
Sunday, 13.09.2009
Respiratory infection caused by Pseudomonas aeruginosa
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The S-carboxymethylcysteine reduces the extracellular slime substance of the
Pseudomonas aeruginosa
biofilm
K. Kishi, S. Otani, A. Iwata, K. Umeki, H. Ishii, R. Shirai, I. Tokimatsu, K. Hiramatsu, J. I. Kadota (Yufu city, Japan)
Source:
Annual Congress 2009 - Respiratory infection caused by Pseudomonas aeruginosa
Session:
Respiratory infection caused by Pseudomonas aeruginosa
Session type:
Oral Presentation
Number:
1364
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Kishi, S. Otani, A. Iwata, K. Umeki, H. Ishii, R. Shirai, I. Tokimatsu, K. Hiramatsu, J. I. Kadota (Yufu city, Japan). The S-carboxymethylcysteine reduces the extracellular slime substance of the
Pseudomonas aeruginosa
biofilm. Eur Respir J 2009; 34: Suppl. 53, 1364
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Effects of erythromycin on Pseudomonas aeruginosa adherence to collagen and morphology in vitro
Source: Eur Respir J 2003; 21: 401-406
Year: 2003
Effect of salbutamol on the growth, virulence and biofilm formation of
pseudomonas aeruginosa
Source: Annual Congress 2011 - Innate and exogenous factors in childhood respiratory infection
Year: 2011
Effects of subinhibitory concentrations of antibiotics on the biofilm formation of pseudomonas aeruginosa
Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis
Year: 2011
Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in vivo
Source: Virtual Congress 2021 – Back to infection basics
Year: 2021
Pseudomonas aeruginosa adherence to human basement membrane collagen in vitro
Source: Eur Respir J 2003; 21: 932-938
Year: 2003
Variation in hydrogen cyanide production between different strains of Pseudomonas aeruginosa
Source: Eur Respir J 2011; 38: 409-414
Year: 2011
The effect on imipenem on the regulation of
ampC
and
oprD
genes in
Pseudomonas
biofilm
Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas
Year: 2010
The filamentous Pseudomonas phage Pf disrupts airway basal cell proliferation
Source: Virtual Congress 2021 – Molecular pathology and cell biology of pulmonary diseases
Year: 2021
Antimicrobial activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and in biofilm
Source: International Congress 2017 – How can microbiology and translational research help physicians?
Year: 2017
Pseudomonas aeruginosa and cyanide production
Source: Eur Respir J 2011; 37: 482-483
Year: 2011
Three-dimensional lung epithelial cells potentiate aminoglycoside efficacy by enhancing intracellular pH in Pseudomonas aeruginosa
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018
Colistin stimulates the activity of neutrophil elastase and Pseudomonas aeruginosa elastase
Source: Eur Respir J 2002; 19: 1136-1141
Year: 2002
Causative bacteria in protracted bacterial bronchitis are biofilm forming species
Source: International Congress 2018 – Orphan diseases in children
Year: 2018
Streptococcus pneumoniae inhibits Pseudomonas aeruginosa growth on nasal human epithelium in vitro
Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies
Year: 2018
Cigarette smoke extract (CSE) alters the secretion profile of the Pseudomonas aeruginosa strain PA14
Source: Annual Congress 2012 - Prognosis and outcome of respiratory infections
Year: 2012
Inhibitory activity of azithromycin on pseudomonas aeruginosa in biofilms
Source: Eur Respir J 2003; 22: Suppl. 45, 450s
Year: 2003
Exploring the susceptibility of P. aeruginosa biofilms in human mucus towards tobramycin treatment
Source: International Congress 2017 – Cystic fibrosis: clinical issues
Year: 2017
Xylitol affects production of virulence factors and biofilm in pseudomonas aeruginosa; effects on respiratory epithelium inflammation. "In vitro" studies
Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science
Year: 2013
Exposure to particulate matter increases pyocyanin production in Pseudomonas aeruginosa
Source: International Congress 2017 – How can microbiology and translational research help physicians?
Year: 2017
Mechanisms of induction of neutrophil apoptosis by the pseudomonas aeruginosa exotoxin pyocyanin
Source: Eur Respir J 2004; 24: Suppl. 48, 107s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept